Vale, BASF, and Talanx see shifts in analyst targets and earnings schedules

Several major corporations are seeing shifts in analyst ratings and upcoming financial reporting schedules.

Barclays has lowered its price target for Vale from 17 to 15 USD, maintaining an ‘Equal Weight’ rating. Vale reported second-quarter revenue of 10.49 billion USD with a net profit of 1.35 billion USD. The company is scheduled to release its next performance report on October 29, 2026.

In the European sector, Parmantier & Cie. has issued a buy recommendation for BASF with a price target of 59.00 EUR, citing the company's position in the European chemical cycle. BASF recently reported second-quarter revenue of 17.21 billion EUR. Meanwhile, Talanx has announced it will release its quarterly statement on November 12, 2026, following a strong first half of the year with a group result of 1.50 billion EUR.

In France, UBS has lowered its price target for Icade to 13.00 EUR from 17.50 EUR, maintaining a sell rating. This follows Icade's mid-year report showing a net loss of 155.90 million EUR. Icade is expected to release quarterly and nine-month figures on October 20, 2026.